Adoptive immunotherapy using activated T cell is recognized to be clinically effective in treating lymphoma, leukemia, and renal cell carcinoma 1 3 . In addition, the ef cacy of these cells in reducing the recurrence after surgical resection of hepatocellular carcinoma HCC has been described 4, 5 . Although we have conducted cell therapy using activated T cells since in 1997, the identities of the effector cells used in this therapy were not elucidated. When we examined the surface markers of the cells administered in effective immunotherapies, we found an abundance of CD56 Tcells. These cells are usually present in the peripheral blood at 5 . However, they were increased ve-fold after activation with immobilized CD3 and IL-2 stimulation. We assessed this cell population with respect to origine, function, and morphology. To determine the fraction from which this population is derived, we conducted the present study using clinically administered, activated T cells. Abstract : Although CD56 T cells comprise less than 5 of human peripheral blood mononuclear cells PBMCs , we observed that the percentage of CD56 T cells was increased in activated T-cell populations used for adoptive immunotherapy. We hypothesized that this cell subpopulation might be an important cytotoxic effector in immunotherapy. PBMCs were obtained from both cancer patients and healthy donors. CD8 single-positive T cells were separated with magnetic beads, and stimulated with immobilized anti-CD3 monoclonal antibody and IL-2. FACS analysis showed that the CD56 antigen was expressed more strongly on CD8 cells than on CD4 cells. The CD8 CD56 T cells have a tendency for more cytotoxic effects than the CD8 CD56 T cells. SEM analysis showed that the CD56 T cells adhered to one another, to form a cluster. Thus, T cell self-adhesion was increased by the expression of the adhesion molecule CD56. The cytotoxic CD8 CD56 T cells derived from CD8 T cells in the peripheral blood are activated T cells that are distinct from natural killer T NKT cells.
Materials and Methods

Cell preparation and culturing
Peripheral blood mononuclear cells PBMCs were isolated from the heparinized blood from normal volunteers and cancer patients using Ficoll-Paque density 1.077 ; Immuno-Biological Laboratories, Japan density gradient centrifugation at 300 g for 15 min. The cells were washed with RPMI 1640 Nikken Bio Medical Laboratories, Japan , and 5 ml of the PBMC suspension were mixed with biomagnetic beads Dynabeads M-450 CD8 ; DYNAL .
The ratio of beads to target cells was 1 : 1, and mixture was incubate for 30 min at 4 with gentle tilting and rotation. The rosetted cells were isolated and washed with the help of a magnet, and resuspended at a concentration of 5 10 5 / ml in RPMI 1640 medium that was suplemented supplemented with 10 heat-inactivated FBS Cell Culture Laboratories, Ohio, U.S.A. recombinant human IL-2 700 U / ml ; Ortho Pharmaceutical, U.S.A. , 2 mM L-glutamine, 1 mM Oxaloacetic acid, 1 mM sodium pyruvate, 0.2 U / ml insulin and antibiotics. Culture flasks 25-mm 2 ; Sumitomo Bakelite, Japan were coated with anti-CD3 antibody 5 g / ml ; Ortho Pharmaceutical, U.S.A. overnight at 4 , and then washed three times with cold PBS. Rosetted cells and 10 ml of the culture medium were added to the coated asks and cultured in 5 CO 2 at 37 for 7 days ; the magnetic beads were removed with a magnet. The cultured cells were transferred to non-antibody-treated asks or Gas permeable bag, so that large-scale cells were obtained 8 .
Flow cytometric analysis
The surface phenotypes of the cells were determined using monoclonal antibodeies mAbs in conjunction with a two-color immunofluorescence. Briefly For SEM analysis, the xed specimens were dehydrated in a graded series of alcohol and substituted with isoamyl acetate for 1 h. After critical-point drying using CO 2 as the transitional uid and sputter coating with gold JEOL ION SPUTTER JFC 1100 , the specimens were observed under the electron microscope.
Cytotoxicity
The lytic capabilities of the cultured cells were assessed using the standard 4-hour 
Results
Phenotypic pro ling
Analyses of surface phenotypes of lymphocytes subjected to activating culturing revealed that the mean percentage of CD8 was 87.4 . The percentage was much higher than that of CD4 cells. The CD56 antigen was expressed more strongly on CD8 cells. The percentage of CD8 CD56 lymphocytes induced from PBMCs by IL-2 and immobilized anti-CD3 mAb was 19.4 , whereas the corresponding percentage of CD4 CD56 was 4.6
. Thus, the percentage of CD8 CD56 cells was more than four-fold higher than the percentage of CD4 CD56 cells Fig. 1 . 
Increase in the population of CD8 CD56 T cells
The expression of CD56 on CD8 T cells scarcely increased during the 7 days of stimulation with immobilized anti-CD3 mAb, which was conducted in accordance with the method reported previously 8 . In the absence of immobilized anti-CD3 mAb, the proportion of CD56-expressing cells increased gradually, reaching 40.6 on day 21 Fig. 2 .
Other surface marker pro les
Using mAb directed against NK receptors, surface markers were analyzed with FACS.
The expression levels of CD158a and CD158b were within the normal ranges, and showed no correlations with the levels of CD56. The expression of CD94 was high even before activation, and was not changed after activation. The Fc receptors found on NK cells were also analyzed using mAbs against CD16, CD32, CD64. The results were negative, and the cells lacked NK cell-like characteristics. For mouse NKT cells, V 14 chain of the T cell receptor has been used selectively, and its human equivalent is considered to be V 24. Staining of the cells with an anti-V 24 mAb gave a negative outcome Table 1 . 
CD8 CD56 cells produce IFN-
The intracellulary cytokine assays revealed that the CD8 CD56 T cells produced mainly IFN-, with negligible production of IL-4. Thus, activation predominantly induced Th1-type cells Table 2 .
Cytotoxicity of CD8 CD56 T cells
The cytotoxic activities of CD8 56 T cell subpopulations separated by positive selection for CD56 were measured using Daudi and K562 cells as the target cells. CD56 fraction served as the control. Both the CD8 56 and CD8 56 T cells exerted cytotoxic effects on the Daudi and K562 cells. The CD8 56 T cells had slightly higher cytotoxic activities, although there was no signi cant difference in this respect between the two subclasses of CD8 T cells Table 3 .
Morphologil analysis
Following the activation of CD8 T cells with IL-2 and solid-phase OKT3, morphologic changes in CD8 T cells of the PBMC population were recognized Fig.3 . The CD8 T cells were sphere-shaped and barely discernible from the CD4 T cells. In parallel with activation, the CD8 T cells became polymorphous. During culturing in a ask, the CD8 CD56 T cells extended in a bipolarly humped shape, and adhered to the bottom of the ask. SEM of the CD8 CD56 T cells revealed that the CD56 T cells adhered to one another, thereby forming a cluster. Concomitant with the expression of CD56, mutual adhesion of T cells increased. N-CAM gene expression in the CD8 56 T cell fraction was stronger than in PBMCs or CD8 CD56 fractions. A low-level expression of N-CAM was rdetected in the CD56-depleted fraction and in the PBMCs whole fraction 6 . As seen in electrophoresis using the -actin gene as the control, N-CAM expression was weak, even though the concentration of cDNA was higher Fig. 4 .
Detection of the N-CAM CD56 gene in the N-CAM-positive fraction and N-CAM-negative fractions
Discussion
We investigated the mechanism by which CD56 T cells appear in the peripheral blood, and examined whether CD8 CD56 T cells are derived from CD8 T cells. In many cases of clinically effective immunotherapy, abundant CD56 T cells have been found among the administered cells. Previously, it was reported that when peripheral blood cells were stimulated with IL-2 and cultured in vitro, CD56 T cells were induced 7 . We investigated the development of CD8 CD56 T cells from CD8 T cells using stimulation with IL-2 and solid-phase OKT3 8 before large-scale culture. The proliferation of pre-existing CD8 CD56 T cells seems unlikely, since it was con rmed that CD8 CD56 T cells could be induced by activation from CD8 T cells from which the CD56 antigen had been removed using magnetic beads prior to culture. These results suggest that activating stimuli induced the expression of CD56 on CD8 56 T cells, aw well as the subsequent proliferation of the CD8 56 T cells.
Morphologic changes were noted for the activated T cells that expressed CD56. CD56 is primarily an adhesion molecule. It is expressed not only on NK cells and a proportion of T cells, but also in the brain, smooth muscle and neural crest-derived epithelium. It is a surface antigen that mediates homotypic adhesion. During culturing in a falk, the lymphocytes adhered to the bottom of the ask. Under light microscopy, the lymphocytes exhibited changes in shape, and electron microscopy revealed mutual lymphocyte adhesion.
RT-PCR with the N-CAM-speci c primer revealed strong expression of CD56 N-CAM mRNA following activation. There was slight expression of CD56 gene in PBMCs, although gene expression associated with activation was considered to be enhanced.
There have been some reports on NKT cells 9, 10 . The CD8 CD56 T cells expressed both the T-cell receptor and NK surface antigen markers. However, the CD8 CD56 T differ from the so-called NKT cells with regard to the expression of CD4, CD8 and V 24. The fact that they scarcely express the FC receptor FCR or NK receptor NKR strongly suggests that the CD8 CD56 T cells that have been activated. Thus, these cells are considered to represent a population that is induced at the stage of differentiation seeen in the peripheral blood.
In the present study, the origin and functions of CD8 CD56 T cells were studied. 
